OMDA
Omada Health, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
23.56
▼ 0.15 (0.63%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
23.86
Prev close
23.71
Day high
24.07
Day low
23.50
Volume
466.45K
Market cap
$1.46B
P/E (TTM)
35.66
52W range
10.28 – 26.92
Insider net activity
Net shares
+693.60K
Net buying
Buy transactions
40
1.08M shares
Sell transactions
35
390.81K shares
Net transactions
+75
Buys less sells
Sell : buy shares
0.4 : 1
Mixed
Insider-held shares
1.31M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 12, 26 | SHAO WEI-LI President |
SELL | 8.87K | $221.80K | Direct |
| Aug 11, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 16.84K | $421.55K | Direct |
| Aug 11, 26 | COOK STEVEN L. Chief Financial Officer |
CONVERSION | 16.84K | $138.75K | Direct |
| Aug 10, 26 | GRACEY CRAIG Officer |
SELL | 1.04K | $26.05K | Direct |
| Aug 10, 26 | DUFFY SEAN P Chief Executive Officer |
SELL | 21.57K | $509.58K | Direct |
| Aug 10, 26 | GRACEY CRAIG Officer |
CONVERSION | 1.04K | $6.85K | Direct |
| Aug 10, 26 | DUFFY SEAN P Chief Executive Officer |
CONVERSION | 21.57K | $193.02K | Direct |
| Aug 3, 26 | DUFFY SEAN P Chief Executive Officer |
SELL | 12.94K | $264.01K | Direct |
| Aug 3, 26 | DUFFY SEAN P Chief Executive Officer |
CONVERSION | 12.94K | $75.33K | Direct |
| Jul 15, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 12.15K | $291.77K | Direct |
| Jul 15, 26 | COOK STEVEN L. Chief Financial Officer |
CONVERSION | 12.15K | $100.60K | Direct |
| Jul 13, 26 | GRACEY CRAIG Officer |
SELL | 1.04K | $24.98K | Direct |
| Jul 13, 26 | COOK STEVEN L. Chief Financial Officer |
SELL | 5.80K | $139.21K | Direct |
| Jul 13, 26 | GRACEY CRAIG Officer |
CONVERSION | 1.04K | $6.84K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEAL ANNE |
Director | 20.62K | Stock Award(Grant) |
COOK STEVEN L. |
Chief Financial Officer | 187.21K | Sale |
DUFFY SEAN P |
Chief Executive Officer | 1.26M | Sale |
FETTER TREVOR |
Director | 135.62K | Stock Award(Grant) |
HILLEMAN JERYL L |
Director | 26.52K | Stock Award(Grant) |
JAIN SACHIN H. |
Director | 20.62K | Stock Award(Grant) |
KLAPSTEIN JULIE D |
Director | 21.96K | Stock Award(Grant) |
REVELATION ALPINE, L.L.C |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
ROOT JONATHAN D |
Director | 191.88K | Stock Award(Grant) |
SHAO WEI-LI |
President | 307.37K | Sale |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
1.50
Put-heavy session
Put / call open interest
0.18
Positioning, not flow
Max pain
22.50
-5.8% from spot
ATM implied vol
60.1%
Nearest strike to spot
Skew (10% OTM)
+14.8%
Puts bid over calls
Call volume
14
Contracts, this expiry
Put volume
21
Contracts, this expiry
Heaviest call OI
25.00
145 contracts
Heaviest put OI
22.50
25 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-0.62%
+0.7%
1M
+12.69%
+9.0%
3M
+45.32%
+42.2%
6M
+105.59%
+94.5%
YTD
+51.39%
+39.1%
1Y
+10.96%
-9.0%
3Y
—
-74.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.46B
Enterprise value$1.24B
Revenue (TTM)$309.76M
Gross profit$211.21M
EBITDA$5.43M
Net income$4.30M
EPS (TTM)$0.67
Free cash flow$11.92M
Total cash$221.71M
Total debt$0
Book value / share$3.95
Shares outstanding61.22M
Float50.85M
Short % of float12.83%
Dividend yield—
Beta (5Y)—
Short interest
Shares short
7.63M
Prior 7.79M
Change vs prior
-2.1%
Shorts covering
% of float
12.83%
Elevated
% of shares out
12.59%
Against total outstanding
Days to cover
6.1
Crowded exit
Float
50.85M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E35.66
Forward P/E42.96
PEG ratio—
Price / sales—
Price / book6.05
EV / revenue4.01
EV / EBITDA228.46
Gross margin68.19%
Operating margin4.04%
Profit margin1.39%
Return on equity1.84%
Return on assets-0.09%
Debt / equity—
Current ratio3.91
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $260.21M | $169.80M | $122.78M | $89.19M | +53.2% |
| Operating revenue | $260.21M | $169.80M | $122.78M | $89.19M | +53.2% |
| Cost of revenue | $89.27M | $66.92M | $52.81M | $46.39M | +33.4% |
| Gross profit | $170.94M | $102.88M | $69.97M | $42.79M | +66.2% |
| Research & development | $40.68M | $35.92M | $33.74M | $26.17M | +13.3% |
| Selling, general & admin | $142.23M | $110.61M | $102.23M | $88.97M | +28.6% |
| Total operating expense | $182.91M | $146.53M | $135.97M | $115.14M | +24.8% |
| Operating income | -$11.97M | -$43.65M | -$66.00M | -$72.35M | +72.6% |
| Net interest income | $2.77M | -$3.70M | $1.07M | -$2.00M | +174.9% |
| Pre-tax income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Net income to common | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Basic EPS | -0.35 | -0.85 | -1.41 | -1.52 | +58.6% |
| Diluted EPS | -0.35 | -0.85 | -1.41 | -1.52 | +58.6% |
| EBIT | -$10.24M | -$42.63M | -$62.81M | -$68.32M | +76.0% |
| EBITDA | -$4.75M | -$37.83M | -$58.36M | -$63.99M | +87.4% |
| Basic shares | 36.64M | 55.74M | 47.72M | 47.72M | -34.3% |
| Diluted shares | 36.64M | 55.74M | 47.72M | 47.72M | -34.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Cash & short-term investments | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Accounts receivable | $13.56M | $9.48M | $7.58M | $4.93M | +43.0% |
| Inventory | $4.49M | $3.30M | $3.61M | $3.54M | +36.1% |
| Total current assets | $272.93M | $113.06M | $142.88M | $188.56M | +141.4% |
| Property, plant & equipment | $7.94M | $6.07M | $5.60M | $6.06M | +30.8% |
| Goodwill & intangibles | $15.65M | $17.50M | $19.51M | $21.55M | -10.6% |
| Total assets | $305.41M | $150.89M | $175.08M | $221.80M | +102.4% |
| Total current liabilities | $75.73M | $53.95M | $43.79M | $34.51M | +40.4% |
| Long-term debt | — | $29.77M | $29.38M | $28.89M | — |
| Total debt | $0 | $30.19M | $30.58M | $30.81M | -100.0% |
| Total liabilities | $75.73M | $535.29M | $76.16M | $66.19M | -85.9% |
| Retained earnings | -$456.74M | -$443.97M | -$396.83M | -$329.32M | -2.9% |
| Shareholder equity | $229.68M | -$384.40M | $98.92M | $155.60M | +159.7% |
| Working capital | $197.21M | $59.11M | $99.09M | $154.04M | +233.7% |
| Net tangible assets | $214.03M | -$401.91M | $79.41M | $134.05M | +153.3% |
| Shares issued | 58.43M | 55.74M | 55.74M | 55.74M | +4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$12.78M | -$47.14M | -$67.51M | -$72.52M | +72.9% |
| Depreciation & amortisation | $5.49M | $4.80M | $4.45M | $4.33M | +14.3% |
| Stock-based compensation | $12.96M | $9.42M | $8.74M | $6.65M | +37.5% |
| Change in working capital | $3.74M | -$6.57M | -$1.50M | -$9.14M | +156.9% |
| Operating cash flow | $18.25M | -$34.18M | -$49.74M | -$68.98M | +153.4% |
| Capital expenditure | -$5.83M | -$3.86M | -$2.92M | -$2.72M | -51.0% |
| Investing cash flow | -$5.83M | -$3.86M | -$2.92M | -$2.72M | -51.0% |
| Financing cash flow | $133.22M | -$1.21M | $179.00K | $16.32M | +11,119.4% |
| Free cash flow | $12.42M | -$38.04M | -$52.66M | -$71.70M | +132.6% |
| End cash position | $222.04M | $76.39M | $115.64M | $168.12M | +190.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $87.83M | $78.05M | $75.85M | $68.03M | $61.37M | +12.5% |
| Operating revenue | $87.83M | $78.05M | $75.85M | $68.03M | $61.37M | +12.5% |
| Cost of revenue | $24.05M | $29.36M | $22.18M | $22.96M | $21.07M | -18.1% |
| Gross profit | $63.79M | $48.69M | $53.66M | $45.07M | $40.31M | +31.0% |
| Research & development | $14.63M | $12.70M | $11.55M | $10.30M | $10.02M | +15.2% |
| Selling, general & admin | $45.61M | $40.78M | $38.83M | $37.28M | $34.63M | +11.9% |
| Total operating expense | $60.24M | $53.47M | $50.38M | $47.58M | $44.65M | +12.6% |
| Operating income | $3.55M | -$4.78M | $3.28M | -$2.51M | -$4.34M | +174.2% |
| Net interest income | $1.75M | $1.81M | $1.88M | $1.66M | -$231.00K | -3.6% |
| Pre-tax income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Net income to common | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Basic EPS | 0.09 | -0.05 | 0.09 | -0.06 | -0.24 | +280.0% |
| Diluted EPS | 0.08 | -0.05 | 0.08 | -0.06 | -0.24 | +260.0% |
| EBIT | $5.31M | -$2.95M | $5.17M | -$2.83M | -$4.22M | +279.8% |
| EBITDA | $6.89M | -$1.44M | $6.62M | -$1.47M | -$2.87M | +577.1% |
| Basic shares | 59.69M | 58.92M | 58.06M | 57.66M | 21.97M | +1.3% |
| Diluted shares | 63.95M | 58.92M | 63.93M | 57.66M | 21.97M | +8.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | — | +4.7% |
| Cash & short-term investments | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | — | +4.7% |
| Accounts receivable | $31.92M | $13.60M | $13.56M | $19.44M | $11.25M | — | +134.6% |
| Inventory | $4.12M | $3.83M | $4.49M | $3.15M | $3.47M | — | +7.5% |
| Total current assets | $294.91M | $269.43M | $272.93M | $254.90M | $271.11M | — | +9.5% |
| Property, plant & equipment | $9.10M | $8.46M | $7.94M | $7.54M | $6.55M | — | +7.6% |
| Goodwill & intangibles | $14.78M | $15.21M | $15.65M | $16.09M | $16.53M | — | -2.9% |
| Total assets | $328.22M | $302.80M | $305.41M | $287.47M | $302.97M | — | +8.4% |
| Total current liabilities | $75.48M | $68.68M | $75.73M | $70.12M | $57.99M | — | +9.9% |
| Long-term debt | — | — | — | — | $29.97M | $29.87M | — |
| Total debt | — | — | $0 | $0 | $29.97M | $30.08M | — |
| Total liabilities | $75.48M | $68.68M | $75.73M | $70.12M | $88.76M | — | +9.9% |
| Retained earnings | -$454.42M | -$459.71M | -$456.74M | -$461.90M | -$458.73M | — | +1.2% |
| Shareholder equity | $252.74M | $234.12M | $229.68M | $217.35M | $214.21M | — | +8.0% |
| Working capital | $219.43M | $200.75M | $197.21M | $184.78M | $213.12M | — | +9.3% |
| Net tangible assets | $237.96M | $218.90M | $214.03M | $201.25M | $197.68M | — | +8.7% |
| Shares issued | 60.61M | 59.24M | 58.43M | 57.89M | 57.32M | — | +2.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $5.29M | -$2.97M | $5.16M | -$3.18M | -$5.31M | +278.2% |
| Depreciation & amortisation | $1.58M | $1.51M | $1.45M | $1.36M | $1.35M | +4.8% |
| Stock-based compensation | $5.63M | $4.21M | $3.75M | $3.54M | $2.83M | +33.8% |
| Change in working capital | -$9.88M | -$16.35M | $10.45M | $4.10M | $2.23M | +39.6% |
| Operating cash flow | $4.01M | -$11.83M | $21.38M | $10.13M | $2.86M | +133.9% |
| Capital expenditure | -$1.66M | -$1.56M | -$1.35M | -$1.99M | -$1.25M | -6.9% |
| Investing cash flow | -$1.66M | -$1.56M | -$1.35M | -$1.99M | -$1.25M | -6.9% |
| Financing cash flow | $7.60M | $3.12M | $3.38M | -$32.66M | $162.14M | +143.7% |
| Free cash flow | $2.34M | -$13.39M | $20.03M | $8.15M | $1.61M | +117.5% |
| End cash position | $221.71M | $211.76M | $222.04M | $198.63M | $223.15M | +4.7% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.06 | 0.20 | +219.8% |
| Mar 2026 | -0.04 | 0.05 | +209.9% |
| Dec 2025 | 0.03 | 0.16 | +467.4% |
| Sep 2025 | -0.07 | 0.03 | +143.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.10 | 4 | $85.64M | +25.9% |
| Next quarter | 0.10 | 4 | $87.00M | +14.7% |
| Current year | 0.44 | 5 | $338.62M | +30.1% |
| Next year | 0.56 | 5 | $407.64M | +20.4% |
Analyst targets & ownership
Mean target$28.25
High target$35.00
Low target$22.00
Implied upside19.91%
Analyst count12
ConsensusBUY
Strong buy / Buy5 / 5
Hold2
Sell / Strong sell0 / 0
Held by insiders2.13%
Held by institutions86.66%
Institutions holding205
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 14, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Aug 12, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Aug 10, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 3, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 20, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Jul 17, 26 | BTIG | INITIATED | — | Buy |
| Jun 22, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 8, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| May 8, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
Moving averages & technicals
SMA 10
24.08
-2.17% from price
SMA 20
22.20
+7.62% from price
SMA 50
21.51
+11.05% from price
SMA 100
18.35
+28.37% from price
SMA 200
16.88
+41.55% from price
EMA 12
23.42
+0.61% from price
EMA 26
22.60
+4.26% from price
EMA 50
21.38
+10.19% from price
RSI (14)
58.6
Neutral
MACD (12,26,9)
0.82
Hist 0.12
ATR (14)
1.26
5.28% of price
Realised vol 30D
69.2%
Annualised
Bollinger upper
26.37
20, 2σ
Bollinger lower
18.03
20, 2σ
50 / 200 cross
Golden
21.51 vs 16.88
Trend bias
Above 200
+41.55%
Risk profile
Beta vs SPY
1.18
More volatile than market
Correlation to SPY
0.26
Largely independent
Realised vol 30D
69.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-59.1%
Peak to trough
Max drawdown 5Y
-59.1%
Peak to trough
ATR 14
1.26
5.28% of price
Beta (reported)
—
5Y monthly, from filing
SEC filings
Periodic Financial Reports
10-Q · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-16
Periodic Financial Reports
10-Q · 2026-05-08
Corporate Changes & Voting Matters
8-K · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-28
Periodic Financial Reports
10-K · 2026-03-06
Corporate Changes & Voting Matters
8-K · 2026-03-05
Headlines
Omada Health (OMDA) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
Omada Health Insider Sold Shares Worth $421,547, According to a Recent SEC Filing
MT Newswires · 10d ago
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
MarketBeat · 11d ago
Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate
Simply Wall St. · 14d ago
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks · 15d ago
Omada Health Q2 Earnings Call Highlights
MarketBeat · 16d ago
Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ...
GuruFocus.com · 16d ago
Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates
Zacks · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.